US Broker Ratings

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 68% Potential Upside

For investors eyeing the healthcare sector, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents an intriguing profile with significant potential upside. This regenerative medicine company, headquartered in Canton,..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring a 150% Potential Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) presents an intriguing opportunity for investors who are keen on the biotechnology sector, particularly those focused on groundbreaking therapies for retinal..

MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a 274% Potential Upside in the Biotech Arena

Investors with a keen eye on the healthcare sector, particularly in the biotechnology industry, may find MBX Biosciences, Inc. (NASDAQ: MBX) a compelling prospect. With a..

Immatics N.V. (IMTX) Investor Outlook: Unveiling a Potential 111.80% Upside in the Biotech Sector

Immatics N.V. (NASDAQ: IMTX), a burgeoning player in the biotechnology sector, stands out with a significant potential upside that captures the attention of both seasoned and..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Biotechnology’s Rising Star with a 242% Potential Upside

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing the attention of investors in the healthcare sector, particularly within the biotechnology industry. This clinical-stage gene therapy company, headquartered..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Promising 107% Upside with Strong Buy Ratings

Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering player in the healthcare sector, particularly in the medical devices industry, is making waves with its innovative approach to..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Uncovering a 313% Potential Upside in Biotech

In the dynamic world of biotechnology, Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands out as a compelling investment opportunity, primarily due to its innovative focus on cell..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Promising 219.91% Upside for Investors

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to cancer treatment. Headquartered in San..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 46.70% Potential Upside

For investors with an eye on the biotechnology sector, Prothena Corporation plc (NASDAQ: PRTA) presents a compelling opportunity, particularly for those interested in companies with significant..

Maravai LifeSciences Holdings (MRVI): Analyst Consensus Points to 43% Upside Potential – Is It Time to Invest?

For investors with a keen eye on the biotechnology sector, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling case, particularly with analysts predicting a potential..

Zymeworks Inc. (ZYME): Investor Outlook on a Biotech Powerhouse with 27% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME) is making waves in the biotechnology sector, and with a potential upside of 27.65% based on analyst target prices, investors are taking..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 9.87% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, is catching the attention of investors with its recent market performance and promising valuation metrics. Known..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a Strong Return on Equity and Revenue Growth in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD) is a standout in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $920.61 million, this Florida-based..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Highs and Lows in the Cannabis Sector

Cronos Group Inc. (NASDAQ: CRON), a leading player in the burgeoning cannabis industry, is capturing investor attention with its strategic focus on cannabinoid innovation and international..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A 107% Potential Upside in the Biotech Arena

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of investors with its promising position in the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in Boulder,..

Claritev Corporation (CTEV) Stock Analysis: 27% Upside Potential Amid Healthcare Innovation

Claritev Corporation (NASDAQ: CTEV), a dynamic player in the healthcare sector, is gaining attention with its robust data analytics and technology-enabled solutions aimed at optimizing the..

PureTech Health plc (PRTC) Stock Analysis: Exploring a 212.93% Upside with Breakthrough Biotech Innovations

PureTech Health plc (NASDAQ: PRTC) is making waves in the biotechnology sector with its innovative pipeline and potential for significant stock price appreciation. With a market..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 62.51% Potential Upside for Investors

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) presents a compelling opportunity for investors with its focus on rare disease treatments and a significant potential upside. The company, based..

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook Amidst a Challenging Biotech Sector

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a pioneering entity in the biotechnology sector, is at the forefront of cell programming and biosecurity. With a market capitalization..

Beta Bionics, Inc. (BBNX) Stock Analysis: A Medical Device Innovator with Robust Growth Potential

Beta Bionics, Inc. (NASDAQ: BBNX) is gaining significant attention from investors due to its innovative approach in the medical devices sector, specifically targeting the diabetes care..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds